EndoPulse
Life-saving Cardiac Support Device
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in April 2025 by Ben Friesem, EndoPulse operates with 1–10 employees. The company has secured funding across one round from one investor. In May 2025, EndoPulse received seed funding from Peregrine Ventures.
Business overview
EndoPulse is a medical device company focused on developing advanced cardiac support solutions. The company's core technology aims to enhance outcomes for patients with critical cardiac conditions by addressing limitations in existing technologies. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Life Support, EndoPulse serves the healthcare industry, targeting providers with its B2B business model.
Company Intelligence Q&A
- When was EndoPulse founded?
- EndoPulse was founded in April 2025.
- Who are the founders of EndoPulse?
- Ben Friesem is a co-founder and CEO of EndoPulse.
- What is EndoPulse's primary focus?
- EndoPulse is a medical device company developing the next generation of life-saving cardiac support, aiming to enhance outcomes for patients with critical cardiac conditions.
- What is the status of EndoPulse's product development?
- EndoPulse's product is currently in the R&D stage, focusing on developing advanced cardiac support solutions to address limitations in existing technologies.